It is still not clear what the drug policy of President Obama will be. He has not appointed his drug czar. Many high-ranking Bush Administration officials have yet to leave office and are still setting the agenda on drug policy.
Allan Clear of the Harm Reduction Coalition made an urgent appeal on the Obama White House to intervene in the current negotiations about the Political Declaration on the 1998 UNGASS review that has to be adopted in March 2009 at the High Level Segment of the Commission on Narcotic Drugs (CND). For more than two million people living with HIV, mainly in Africa, hopes are high for a change in Obama's foreign policy.
The US delegation in Vienna continues to block any inclusion of harm reduction in the new Political Declaration – to be approved in March 2009 at the high-level segment of the 52nd session of the Commission on Narcotic Drugs. Three members of the US Congress have written a letter to the new US Ambassador to the UN, Susan Rice, to call for new instructions to be given to the delegation.
“We will be aiming for no less than securing the inclusion of harm reduction in the political declaration by which member states determine international drugs policy,” the Dutch Minister for Development Cooperation Bert Koenders told the Donor Conference on Harm Reduction that took place on January 28-30, 2009, in Amsterdam. “We will do the same when, in 2010, the honour of chairing the UNAIDS governing board falls to the Netherlands. You can count on that.”
Marco Perduca and Donatella Poretti, senators of the Radical Party have asked the Italian under-secretary on drug issues, Carlo Giovanardi, if it is true that Italy has abandoned the common position of the European Union on harm reduction in the negotiations for the Political Declaration for the High-level Segment of the 52nd Commission on Narcotic Drugs (CND) in Vienna. They requested an explanation from the under-secretary why and on what grounds this happened.
Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
15 မတ်လ 2009
This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.